Search

Search Constraints

You searched for: Author/Creator Schorb, Elisabeth

Search Results

3. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021)

5. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Issue 5 (May 2016)

6. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas. Issue 9 (20th March 2023)

7. High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix). Issue 1 (December 2016)

8. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Issue 8 (August 2016)

9. Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single‐centre analysis. (26th May 2020)

10. Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice. (29th January 2020)